BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12358640)

  • 1. Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
    Behrens JR; Rasche L; Gieß RM; Pfuhl C; Wakonig K; Freitag E; Deuschle K; Bellmann-Strobl J; Paul F; Ruprecht K; Dörr J
    Eur J Neurol; 2016 Jan; 23(1):62-7. PubMed ID: 26220765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menaquinone-7 as a novel pharmacological therapy in the treatment of rheumatoid arthritis: A clinical study.
    Abdel-Rahman MS; Alkady EA; Ahmed S
    Eur J Pharmacol; 2015 Aug; 761():273-8. PubMed ID: 26073022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vitamin K in postmenopausal women: mini review.
    Guralp O; Erel CT
    Maturitas; 2014 Mar; 77(3):294-9. PubMed ID: 24342502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K and bone health.
    Hamidi MS; Gajic-Veljanoski O; Cheung AM
    J Clin Densitom; 2013; 16(4):409-13. PubMed ID: 24090644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of vitamin D toxicity.
    Jones G
    Am J Clin Nutr; 2008 Aug; 88(2):582S-586S. PubMed ID: 18689406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Toxicology of Vitamin D in Pediatrics: A Review and Case Reports.
    Levita J; Wilar G; Wahyuni I; Bawono LC; Ramadaini T; Rohani R; Diantini A
    Toxics; 2023 Jul; 11(7):. PubMed ID: 37505607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically Based Pharmacokinetic Modeling of Vitamin D
    Sawyer CW; Tuey SM; West RE; Nolin TD; Joy MS
    Drug Metab Dispos; 2022 Sep; 50(9):1161-1169. PubMed ID: 35779863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the High Prevalence of Vitamin D Deficiency in African Americans Contribute to Health Disparities?
    Ames BN; Grant WB; Willett WC
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33546262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment of hypoparathyroidism: Theory versus reality waiting guidelines for children and adolescents.
    Di Maio S; Soliman AT; De Sanctis V; Kattamis CC
    Acta Biomed; 2018 Mar; 89(1):122-131. PubMed ID: 29633734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of CFTR gene expression by 1,25(OH)
    DiFranco KM; Mulligan JK; Sumal AS; Diamond G
    J Steroid Biochem Mol Biol; 2017 Oct; 173():323-332. PubMed ID: 28130182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of calcitriol with calcium carbonate supplementation on inflammatory biomarkers in chronic kidney disease patients' with low vitamin D.
    Mustafar RB; Mohd R; Miswan NA; Bain A; Cader R; Gafor AH; Mohammad M; Shah SA; Kamaruddin NA; Kong NC
    Cent Eur J Immunol; 2014; 39(2):236-42. PubMed ID: 26155130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism.
    Wang XX; Jiang T; Shen Y; Santamaria H; Solis N; Arbeeny C; Levi M
    Am J Physiol Renal Physiol; 2011 Mar; 300(3):F801-10. PubMed ID: 21209008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol.
    Hansen D; Brandi L; Rasmussen K
    BMC Nephrol; 2009 Sep; 10():28. PubMed ID: 19778452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer.
    Attia S; Eickhoff J; Wilding G; McNeel D; Blank J; Ahuja H; Jumonville A; Eastman M; Shevrin D; Glode M; Alberti D; Staab MJ; Horvath D; Straus J; Marnocha R; Liu G
    Clin Cancer Res; 2008 Apr; 14(8):2437-43. PubMed ID: 18413835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational models to assign biopharmaceutics drug disposition classification from molecular structure.
    Khandelwal A; Bahadduri PM; Chang C; Polli JE; Swaan PW; Ekins S
    Pharm Res; 2007 Dec; 24(12):2249-62. PubMed ID: 17846869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Vitamin D analogues for osteodystrophy in chronic kidney disease.
    Cunningham J
    Pediatr Nephrol; 2004 Jul; 19(7):705-8. PubMed ID: 15141342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative review of the pharmacokinetics of vitamin D analogues.
    Bailie GR; Johnson CA
    Semin Dial; 2002; 15(5):352-7. PubMed ID: 12358640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality rates do not differ among patients prescribed various vitamin D agents.
    Bond TC; Wilson S; Moran J; Krishnan M
    Perit Dial Int; 2015; 35(1):62-9. PubMed ID: 24584595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Oral Paricalcitol and Calcitriol Treatment on Peritoneal Membrane Characteristics of Peritoneal Dialysis Patients - A Pilot Study.
    Farhat K; Stavenuiter AWD; Vervloet MG; Ter Wee PM; Beelen RHJ; van Ittersum FJ
    Perit Dial Int; 2018; 38(3):220-228. PubMed ID: 29386308
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.